Introduction 52
The development of biophysically informed models of cognition and cognitive disorders would 53 facilitate the effective translation of the mechanisms and treatments of disease. In recent years 54 there has been progress towards detailed generative models that replicate neurophysiological 55 correlates of cognition based on cellular and network dynamics. Such 'Dynamic Causal Models' 56 (DCM) make spatiotemporal and spectral predictions that approximate observations by functional 57 magnetic resonance imaging or electro-and magneto-encephalography (MEG) (Moran et al., 2013) . 58
To be most useful, these models should incorporate laminar, cellular and synaptic functions (Bastos 59 et al., 2012) , and adhere to basic principles of cortical connectivity (Shipp, 2016) , while also being 60 sufficiently tractable and accurate to study human cognition. 61
The DCM framework developed to meet these criteria, with applications in health and neurological 62 disorders Stephan et al., 2008; Boly et al., 2011; Marreiros et al., 2015) . DCM 63 models draw on empirical priors for synaptic time constants and conductances, together with a 64 mean-field forward model for each major neuronal class. For each brain region, subject and 65 condition the models' parameters are optimised by inversion to neurophysiological data. Although 66 such models are supported by extensive data for face-validity (Stephan et al., , 2015 and 67 construct-validity (Razi et al., 2015) , it is critical that they also achieve predictive validity (Moran et 68 al., 2014; Shaw et al., 2018) . 69
We therefore undertook DCM of human frontotemporal cortical networks during a roving auditory 70 oddball paradigm, during which sequences of tones are presented that intermittently change in 71 frequency. The first instance of each frequency change is considered a 'deviant tone', which 72 gradually becomes a 'standard' through repetition. Auditory oddball paradigms reveal characteristic 73 early (<300ms) MEG responses to standard and deviant tones. The differential response to these 74 tones (the Mismatch Negativity, MMN) is abnormal in many neurological diseases (Boly et al., 2011; 75 Naatanen et al., 2011; . The MMN has been proposed to represent a prediction 76 error in hierarchical frontotemporal networks (Garrido et al., 2009b; Phillips et al., 2015) . However, 77 earlier models did not reveal the mechanisms of laminar or synaptic function that generate the 78 MMN within the frontal and temporal cortex. 79
To examine laminar-level dynamics in response to auditory stimuli we used an extended-DCM. In six 80 connected frontotemporal regions (based on Phillips et al., 2015 Phillips et al., , 2016 , we used a conductance-81 based canonical mean-field cortical modelling scheme (Moran et al., 2013; Marreiros et al., 2015) . 82
We introduce cortico-thalamic cells with intrinsic conductances implicated in burst-firing that enable 83 the model to generate beta activity involved in the transfer of deep-layer information (Roopun et al., 84 2008a (Roopun et al., 84 , 2010 Bordas et al., 2015; Michalareas et al., 2016) . We also employ separate inhibitory 85 interneuronal populations for superficial and deep pyramidal cells (e.g. Jiang et al., 2015) . These 86 extensions improve the model's functionality in terms of cortico-cortical and cortico-thalamocortical 87 transmission and provide a substrate for the greater separation of laminar dynamics. We tested the 88 model's ability to accurately generate evoked magnetoencephalographic responses (i.e. event 89 related fields, ERF). 90
We used the drug tiagabine to test how well the neurophysiological model could identify changes in 91 the causes of neuronal dynamics. Tiagabine inhibits re-uptake of the inhibitory neurotransmitter 92 gamma-amino-butyric acid (GABA), which is critical for the generation of physiological responses and 93 rhythms in local and global processing (Whittington et al., 2000) . This pharmacological specificity 94 provides a more controlled test of dynamic causal models than autoimmune (Symmonds et al., 95 2018) and genetic channelopathies thresholding. Spectral analyses were performed using a multi-taper method. The deviant trial was 138 taken as the 1 st trial of a train, regardless of the frequency and the 6 th trial of a train was modelled as 139 'standard'. Time-frequency analysis was performed in SPM12 using a multi-taper method with 100 ms windows 153 overlapped by 5 ms and a bandwidth of 3. Frequency bands were split into alpha (8 -13 Hz), beta 154 (14 -29 Hz), low gamma (30 -48 Hz) and high gamma (52 -80 Hz). 155
Neuronal Modelling: an extended canonical microcircuit model 156
We used conductance-based canonical mean field (CMM) models for evoked responses (Kiebel et al., 157 2008) utilising canonical microcircuit models (SPM12, DCM10). This approach to 158 neurophysiologically informed modelling using DCM goes beyond descriptive biomarkers by 159 providing a mechanistic link to realistic microscopic processes. A common approach in DCM is to 160 invert the neuronal and spatial forward model as a single generative model, to solve the source 161 reconstruction and biophysical modelling problems jointly by fitting the DCM to sensor data. 162
However, we modelled source specific responses to suppress conditional dependencies between the 163 neuronal parameters and the parameters of a spatial forward model. This affords more efficient 164 estimators of neuronal parameters, providing the source reconstruction is sufficiently precise given 165 the spatial topography of the network of interest. This has the advantage of compatibility with 166 multiple studies of this task ( coupled with a different cell capacitance, differentiated the intrinsic activation of the 'tp' population 187 from the 'dp' population. The populations also differed in their extrinsic connectivities, with 'dp' 188 populations forming cortico-cortical connections and 'tp' populations allowing for cortico-189 thalamocortical connections. Thalamic activity was not specifically modelled but is represented by 190 an 80 ms delay in connectivity. 191
Extrinsic connectivity between the six nodes is shown in Fig. 1b 
Bayesian Modelling and Statistical Analysis:
We used Bayesian model inversion and selection to identify the best explanation for subject-specific 204 data, in terms of neuronal and biophysical parameters. Parametric Empirical Bayes was used for 205 group inferences and to examine drug effects. 206
The DCM was inverted to source-reconstructed ERF data for the 6 nodes for each subject. Data were 207 filtered between 0-48 Hz and a Tukey window was applied that did not attenuate signals 50 ms 208 before or 350 ms after stimuli. Model inversion was run separately for the standard and deviant 209 trials and passed to second level Parametric Empirical Bayesian with contrasts for both trial types 210 and drug conditions. All intrinsic and extrinsic AMPA, NMDA and GABA-A conductance scalings could 211 vary independently in a manner that assumed symmetry between the two hemispheres. The prior 212 means and permitted variances are summarised in Table 1 . The difference waveform (i.e. the deviant -the standard) reveals a typical biphasic MMN between 238 150-250ms, observed in primary auditory cortex and STG ( Fig. 2a, third row) . Tiagabine significantly 239 reduced the second peak of the MMN (p<0.05) with bilateral IFG nodes and RSTG showing 240 reductions in the first peak of the mismatch response on tiagabine (p<0.05). As with the deviant 241 response, LIFG showed a significant reduction of the later MMN peak and the M300 on tiagabine 242 (p<0.05). 243
The temporal profile of spectral power differences (see Methods for time-frequency analysis) 244 matched that of the ERFs, including spectral counterparts to M100, MMN, continuing through the 245 M300 window (Fig. 2b&c ). During the M100, alpha-power (8-12 Hz) decreases on tiagabine were 246 localized to temporal cortex and beta (14-29 Hz) decreases more prominently to posterior temporal 247 cortex. During the MMN, increases in low and high gamma (30-48 Hz and 52-80 Hz respectively) 248 were observed broadly across right frontal cortex, including IFG. Low gamma also showed increases 249 in right temporal cortex. Figure 4 shows the effect of 266 tiagabine on the intrinsic GABAergic connectivity, assuming symmetry (three bilateral averaged 267 nodes are shown). We confirmed that tiagabine significantly increases tonic GABAergic inhibition 268 (posterior probability given for each parameter in Fig. 4a ). This was seen primarily in the deep layer 269 pyramidal and interneuron populations (Fig 4a) . 270
In keeping with the functional differentiation of upper versus lower levels in a hierarchical neural 271 network with backwards-prediction and forward-prediction error, there was an interaction between 272
the effects of tiagabine and condition between regions: Fig 4b compares GABA-A conductance 273 scaling on deep interneurons between placebo and tiagabine conditions, plotted for each individual. 274
The differences were significant (standard paired t-test, p=1.1e-8) between the two groups in 275 primary auditory areas for the standard condition, and in IFG for the deviant condition. 276
The correlation between tonic and phasic inhibition was also explored for each region and condition 277 and a strong negative relationship was found between the tonic inhibition of deep inhibitory cells 278 and their phasic inhibition onto cortico-thalamic cells (Fig. 4c p=9.0e-8, Bonferroni corrected). 279
Finally, we used the estimated parameters for the 20 individuals in a linear support vector machine 280 with 5-fold cross-validation to classify the conditions under which data were acquired and for which 281 the models were therefore optimised. Parameter based classification reached 92.5% accuracy. 282
Discussion 284
The principle insights from this study are (i): an extended conductance-based canonical mean-field 285 method of dynamic causal modelling ("ext-DCM") is tractable and accurate for generating event-286 related fields that match those observed by magnetoencephalography; and (ii) we confirmed the 287 modulation of GABAergic dynamics by the GABA-reuptake inhibitor tiagabine, opening the way for 288 psychopharmacological studies in health and disease with the mechanistic precision afforded by 289 using ext-DCMs as generative models. In the following sections, we first discuss how MEG quantifies the effects of tiagabine on cortical 298 dynamics. We then consider additional insights from biophysically informed DCMs of hierarchical 299 brain networks, illustrating mechanistic explanations of the observed population dynamics. 300
Understanding the MMN in terms of short-term plasticity. 301
The drug modulation of GABA resulted in complex dynamics across the trial types, implicating both 302 local tonic-phasic effects and global hierarchical effects. Repetitive activation with the same stimulus 303 results in a dampening effect on the ERF (reduction in N1/N2 by 6 th repetition), Fig 2. We predicted 304 higher tonic inhibition in the deep layers during the repetition state -namely, increased tonic 305 inhibition in cortico-cortical circuitry in prefrontal cortex and cortico-thalamo-cortical circuitry in 306 temporal cortex -which we interpret as local short-term plastic changes in deep-layer inhibition 307 (Knott et al., 2002; Hensch, 2005; Jääskeläinen et al., 2007 ) that regulates salient information 308 (Mongillo et al., 2018) . 309
The model confirmed that the effect of tiagabine was to increase extracellular GABA concentrations 310 with a marked increase in tonic inhibition, associated with overspill of GABA onto extra-synaptic 311 receptors (Semyanov et al., 2004) . The effect was modulated differently in primary and secondary 312 processing areas: for tonic inhibition of deep interneurons the drug's efficacy was highest in 313 prefrontal cortex for deviant trials and in auditory cortex for standard trials. Figure 4b Conversely, it has been shown that gamma-band activity is dependent on the GABA-A receptor 333 activation and the phasic interplay of interneuron-pyramidal cell networks, particularly in the 334 superficial layers (Buffalo et al., 2011; Whittington et al., 2011) . Our evidence from the mismatch 335 temporal window (Fig. 2b) indicates peak gamma increases occurring at the start of the mismatch 336 period. This is consistent with thalamic input Barth, 1992, 1993; Sukov and Barth, 2001 ) 337 leading to an envelope of gamma activity in the superficial layers of cortex during audition 338 (Metherate and Cruikshank, 1999) . 339
Overall, the observed dynamics and the model posterior parameters are consistent with our 340 knowledge of network activation within the context of beta-and gamma-rhythm generation in 341 cortex and how increases in endogenous GABA could manifest. 342
Generative models of drug effects on cognitive physiology. 343
The drug's effect was largely confined to deep cells that in turn connect to superficial cells, with 344 tiagabine reducing deep-layer influences on superficial layers. As we modelled evoked activity it is 345 difficult to speculate on how this influences gamma activity across the network, however a reduction 346 in deep-layer influence may increase local cortical processing associated with gamma-band activity 347 in the superficial layers. Under the assumption that their GABA levels are lower in older versus 348 younger adults, tiagabine acts restoratively to increase gamma-band activity by altering the balance 349 of activity across layers. This is corroborated with lower frequency band activity, dependent on 350 GABA (Mathias et al., 2001) . Finally, we speculate that the reduced M100 seen on tiagabine is a 351 consequence of the widespread increased tonic inhibition predicted by the model (Fig. 4) , causing a 352 general reduction in local population activity. 353
Study limitations. 354
Our study was motivated by the need for mechanistic studies of human cortical function, underlying 355 cognition, disease and therapeutics. Despite support for our three principal hypotheses, and 356 background validation studies (Moran et al., 2014) , evidence from one study may not generalise to other tasks and populations. There are some study-specific considerations that limit our inferences, 358 in relation to our participants, our model, and drug of choice. For example, our participants were 359 healthy, but they were older than those studied by Nutt et al (2015) , and therefore have normal age 360 related changes in GABA (Gao et al., 2013; Eavri et al., 2018) , that could interact with the effects of 361 tiagabine (Nutt et al., 2015) . 362
Our neuronal model provides a simplified substrate for the neurophysiological processes. It is more 363 detailed than previously canonical microcircuit convolution models (Moran et al., 2013) The difference wave (MMN) is also shown. ERFs from the placebo condition are shown in blue and 722 from the tiagabine condition in red. Significant (p<0.05) changes with time across the drug condition 723 are shown as a thick black line within each axis. Shaded areas represent the standard error (SEM). 724 b. Significant differences for induced spectra power were found in the alpha (α), beta (β) and lower 725 and higher gamma bands (γ1 and γ2). Here they are shown as flat scalp maps (lower plots) with 726 rostro-caudal activity versus time (upper plots). The time axis runs from 0-380 ms post-stimulus. Table 1 
